secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2021-11-19T23:59:59+00:00
Accession:  0001193125-21-334588
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Neoleukin Therapeutics General Counsel Holly Vance resigns
----------------------------------------------------------

- Holly Vance resigns as General Counsel and Corporate Secretary effective Nov 17, 2021 to pursue another opportunity.
- Transition period under negotiation; Vance expected to provide consulting services as needed.
- No replacement named; CFO Robert Ho signs the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000119312521334588/0001193125-21-334588-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000119312521334588/d259869d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-334588

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer